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Abstract
Heterozygous GATA2 mutation is associated with immunodeficiency, lymphedema, and myelodysplastic syndrome. Disease presentation is variable, often coinciding with loss of circulating dendritic cells, monocytes, B cells, and NK cells. Nonetheless, in a proportion of patients carrying GATA2 mutation, NK cells persist. We found that peripheral blood NK cells in symptomatic patients uniformly lacked expression of the transcription factor PLZF, as well as expression of intracellular signaling proteins FcεRγ, SYK, and EAT-2 in a variegated manner. Moreover, consistent with an adaptive identity, NK cells from patients with GATA2 mutation displayed altered expression of cytotoxic granule constituents and produced IFN-γ upon Fc-receptor engagement but not following combined IL-12 and IL-18 stimulation.
Canonical, PLZF-expressing NK cells were retained in asymptomatic carriers of GATA2 mutation. Developmentally, GATA-2 was expressed in hematopoietic stem cells, but not in Moreover, our data suggests that adaptive NK cells are more long-lived than canonical, immunoregulatory NK cells.
INTRODUCTION
Loss-of-function mutations in GATA2 are associated with an autosomal dominant, typically adult-onset syndrome with variable clinical presentation, yet high mortality. 1, 2 Patients may present with severe mycobacterial, papilloma virus and herpes virus family infections, lymphedema, hypocellular bone marrow failure or myelodysplastic syndrome (MDS) evolving to acute myeloid leukemia (AML). [3] [4] [5] [6] [7] [8] [9] GATA-2 is a transcription factor required for hematopoietic stem and progenitor cell (HSPC) survival and proliferation. 10, 11 GATA-2 haploinsufficiency generally manifests in a progressive loss of monocytes, dendritic cells, B cells and natural killer (NK) cells, leading to increased susceptibility to certain infections. 3, 4, [12] [13] [14] Reduction of monocyte, B cell as well as CD4 + T cell numbers is associated with symptomatic disease, whereas cytotoxic effector CD8 + T cell numbers generally persist. 1, 2 Remarkably, an index case of selective NK cell-deficiency associated with severe herpes virus infections including varicella, cytomegalovirus (CMV), and herpes simplex virus (HSV), 15 was later found to harbor a heterozygous GATA2 mutation. 16 With respect to NK cells, GATA2 mutation is associated with a loss of CD3 -CD56 bright NK cells, whereas differentiated CD3 -CD56 dim NK cell curiously persist in some patients. 1, 16 NK cells are lymphocytes that act at the interface between innate and adaptive immunity. 17 They can eradicate infected and neoplastic cells, as well as autologous activated immune cells, by targeted release of cytotoxic granules containing perforin and granzymes. For cell lines and antibodies, see the Online Supplemental Data.
Moreover, NK cells can relay signals to other immune cells, producing interferon (IFN)-γ in response to target cells or combinations of exogenous cytokines such as interleukin (IL)
-
Flow cytometry
For phenotypic analyses, PBMC were surface stained with fluorochrome-conjugated antibodies as indicated and a fixable dead cell stain (Invitrogen), fixed in 2% formaldehyde (Polysciences) in PBS, and permeabilized in 0.05% Triton X-100 (Sigma-Aldrich) in PBS for intracellular staining. For functional analyses, lymphocytes were stimulated, surface stained with antibodies and a fixable dead cell stain, as previously described. 24, 29 In experiments measuring cytokine production, GolgiPlug (BD Bioscience) was added during stimulation.
Flow cytometry data acquisition and analyses are detailed in the Online Supplemental Data.
Transcription factor cloning and interaction studies
See Online Supplemental Data.
Ex vivo NK cell expansions
RESULTS

Predominance of NK cells lacking PLZF expression in patients with heterozygous GATA2 mutation
Previous reports of patients with heterozygous GATA2 mutation have described heterogeneity in NK cell numbers, with some individuals having high frequencies of differentiated peripheral blood NK cells despite loss of less mature CD3 -CD56 bright cells. 1, 16 Sparked by the characterization of long-lived NK cells in mice, 23 we hypothesized that residual NK cells in human patients with bone marrow failure might constitute adaptive cells.
We analyzed ten adult patients with GATA2 mutation and clinical manifestations, in addition to three asymptomatic adult carriers ( Table 1) . As expected, most patients had markedly elevated levels of circulating FLT-3 ligand, and markedly reduced but heterogeneous peripheral blood B cell, monocyte and NK cell counts ( Figure 1A) . The majority of patients displayed reduced frequencies of CD3 -CD56 bright NK cells, as previously described, 1, 16, 30 whereas asymptomatic carriers maintained these cells ( Figure 1B ; Table S1, Table S2 ). Of note, 4/6 GATA2 mutated patients and asymptomatic carriers retaining CD3 -CD56 bright NK cells were CMV seronegative with the remaining 2 having unknown CMV status at the time of blood collection ( Figure 1B) .
CMV-associated adaptive NK cells have been defined as CD57 + NKG2C + NK cells.
31
Frequencies of CD57-expressing CD3 -CD56 dim NK cells were elevated in patients with GATA2 mutation, but normal in asymptomatic carriers ( Figure 1C , Table S1, Table S2 ).
Three patients displayed exceedingly high frequencies of NKG2C-expressing CD3 -CD56 dim NK cells ( Figure 1D) 
GATA-2 is expressed in hematopoietic stem and progenitor cells but not in NK cell progenitors or differentiated cells
GATA-2 is required for survival and proliferation of HSPCs 35 and, interestingly, has been reported to bind PLZF. 36 We confirmed this biochemical interaction by transient transfection 
Impaired NK cell differentiation from lineage negative cells in individuals with GATA2 mutation
To further understand the impact of GATA-2 haploinsufficiency on NK cell differentiation and proliferation, we adopted an ex vivo NK cell expansion method with the potential to expand NK cell progenitors from the blood. 40,41 Blood samples from healthy controls and from seven individuals with heterozygous GATA2 mutation were studied ( Latency is maintained by suppression of miR-92a leading to up-regulation of GATA-2, promoting IL-10 production that inhibits T cell immunity and stem cell apoptosis. 
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